The relationship between different assays for detection and quantification of amyloid beta 42 in human cerebrospinal fluid

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Ellis, Teresa A ^a   Li, Jinhe ^a   Leblond, David ^a   Waring, Jeffrey F ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 84862294496     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/984746     Document Type: Article

References (7)

1. Blennow K., Vanmechelen E., Hampel H., CSF total tau, A 42 and phosphorylated tau protein as biomarkers for Alzheimer's disease Molecular Neurobiology 2001 24 13 87 97 (Pubitemid 34066679)
2. Mulder C., Verwey N. A., Van Der Flier W. M., Bouwman F. H., Kok A., Van Elk E. J., Scheltens P., Blankenstein M. A., Amyloid- (142), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease Clinical Chemistry 2010 56 2 248 253
3. Bjerke M., Portelius E., Minthon L., Wallin A., Anckarster H., Anckarster R., Andreasen N., Zetterberg H., Andreasson U., Blennow K., Confounding factors influencing amyloid concentration in cerebrospinal fluid International Journal of Alzheimer's Disease 2010 2010 11
4. Schoonenboom N. S. M., Mulder C., Vanderstichele H., Pijnenburg Y. A. L., Van Kamp G. J., Scheltens P., Mehta P. D., Blankenstein M. A., Differences and similarities between two frequently used assays for amyloid 42 in cerebrospinal fluid Clinical Chemistry 2005 51 6 1057 1060 (Pubitemid 40740899)
5. Mattsson N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., Herukka S. K., Van Der Flier W. M., Blankenstein M. A., Ewers M., Rich K., Kaiser E., Verbeek M., Tsolaki M., Mulugeta E., Rosén E., Aarsland D., Jelle Visser P., Schrder J., Marcusson J., De Leon M., Hampel H., Scheltens P., Pirttil T., Wallin A., Eriksdotter Jnhagen M., Minthon L., Winblad B., Blennow K., CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment Journal of the American Medical Association 2009 302 4 385 393
6. Sunderland T., Linker G., Mirza N., Putnam K. T., Friedman D. L., Kimmel L. H., Bergeson J., Manetti G. J., Zimmermann M., Tang B., Bartko J. J., Cohen R. M., Decreased -Amyloid1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients with Alzheimer Disease Journal of the American Medical Association 2003 289 16 2094 2103 (Pubitemid 37430211)
7. Reijn T. S. M., Rikkert M. O., Van Geel W. J. A., de Jong D., Verbeek M. M., Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid 42 and tau proteins Clinical Chemistry 2007 53 5 859 865 (Pubitemid 46744241)